Mefenamic Acid Dawa

Mefenamic Acid, the active ingredient in Mefenamic Acid Dawa, is a fenamate (NSAID) presented as an oral tablet for oral use. It is employed to relieve mild to moderate pain, dysmenorrhea, and musculoskeletal inflammation in adult patients. It belongs to the analgesic and anti‑inflammatory therapeutic class and works by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis.

GNH USA supplies Mefenamic Acid Dawa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality compliance and reliable logistics.

Mefenamic Acid is a non‑selective NSAID that reduces inflammation and pain by inhibiting prostaglandin synthesis. - Dysmenorrhea: provides relief from menstrual cramps and associated pelvic pain. - Musculoskeletal pain: alleviates pain and inflammation in joints, muscles and soft tissues. - Acute mild to moderate pain: reduces pain intensity from various short‑term conditions such as dental or postoperative discomfort.

Mefenamic Acid may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, abdominal pain or dyspepsia. - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Peptic ulcer or gastrointestinal bleeding: severe abdominal pain or blood in stool. - Renal impairment: reduced urine output or swelling. - Hepatotoxicity: jaundice or elevated liver enzymes. - Anaphylaxis: sudden difficulty breathing, swelling of face or throat.

When prescribing Mefenamic Acid, clinicians should consider several precautionary measures to minimize risk. - Assess gastrointestinal risk: evaluate history of ulcers or bleeding before use. - Monitor renal function: avoid in patients with severe kidney impairment. - Check hepatic status: use cautiously in liver disease. - Avoid concurrent NSAIDs: increase risk of adverse effects. - Pregnancy and lactation: use only if benefits outweigh risks, as safety data are limited. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Mefenamic Acid can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): elevated risk of bleeding.

Moderate Interactions (Monitor Closely): - ACE inhibitors or diuretics: possible reduction in renal function. - Lithium: NSAIDs may raise lithium serum levels. - Methotrexate: decreased renal clearance leading to toxicity.